US health product giant Johnson and Johnson (J&J) late on Friday agreed to pay more for troubled medical device maker Guidant, raising its bid to US$24.2 billion in the face of a competing offer from a Massachusetts-based rival.
The board of directors of Indianapolis, Indiana-based Guidant Corporation said it has immediately accepted the new terms, signaling their determination to accept the acquisition by the New Brunswick, New Jersey-based conglomerate
Under the deal, which has now been revised at least three times, J&J will pay US$40.52 in cash and 0.493 shares of its common stock for each outstanding share of Guidant stock.
This means Guidant shareholders will receive a total US$71 a share based on Friday's market close.
On Wednesday, J&J agreed to pay for Guidant US$23.2 billion, or US$68.06 per share.
But a rival bidder, Boston Scientific, raised its offer for Guidant from US$72 to US$73 a share on Thursday, forcing J&J into a bidding war.
The deal still has to be approved by Guidant shareholders at a meeting scheduled for Jan. 31, and J&J's sweetened offer appeared to be aimed at winning shareholders' approval.
"This agreement with Johnson and Johnson provides significant financial value and certainty for shareholders," James Cornelius, Guidant chairman and chief executive officer, said in a statement.
He added that the two companies will have the resources to continue to build upon the existing Guidant businesses and pursue "meaningful innovations" to address cardiovascular disease.
J&J chairman and CEO William Weldon indicated the companies are determined to begin to implement integration plans they have been developing throughout the past year.
"Together, we are ready to execute our plans focused on creating the world's broadest and most comprehensive cardiovascular device company that will bring meaningful technology solutions to address this devastating disease," he said.
J&J, which has more than 200 operating companies and employs nearly 115,000 people around the world, began pursuing Guidant in December 2004, first bidding US$76 a share.
It lowered its offer eleven months later to US$63.08, citing concerns about Guidant's financial outlook.
Since June, Guidant has recalled or issued safety warnings for about 88,000 heart defibrillators and almost 200,000 pacemakers, core products that Johnson and Johnson says it plans to shore up after the merger is complete.
Adding to Guidant's woes, US federal prosecutors in Minnesota and Massachusetts have issued subpoenas seeking more information on the recalled devices. And New York Attorney General Eliot Spitzer filed suit against Guidant for allegedly failing to inform doctors about a suspected flaw in one of its recalled heart defibrillators.
Its financial and legal woes notwithstanding, Guidant remains attractive to outside bidders because it owns rights to a line of drug-coated stents -- tiny devices used to open clogged arteries for people suffering from life-threatening heart conditions.
SEEKING CLARITY: Washington should not adopt measures that create uncertainties for ‘existing semiconductor investments,’ TSMC said referring to its US$165 billion in the US Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) told the US that any future tariffs on Taiwanese semiconductors could reduce demand for chips and derail its pledge to increase its investment in Arizona. “New import restrictions could jeopardize current US leadership in the competitive technology industry and create uncertainties for many committed semiconductor capital projects in the US, including TSMC Arizona’s significant investment plan in Phoenix,” the chipmaker wrote in a letter to the US Department of Commerce. TSMC issued the warning in response to a solicitation for comments by the department on a possible tariff on semiconductor imports by US President Donald Trump’s
‘FAILED EXPORT CONTROLS’: Jensen Huang said that Washington should maximize the speed of AI diffusion, because not doing so would give competitors an advantage Nvidia Corp cofounder and chief executive officer Jensen Huang (黃仁勳) yesterday criticized the US government’s restrictions on exports of artificial intelligence (AI) chips to China, saying that the policy was a failure and would only spur China to accelerate AI development. The export controls gave China the spirit, motivation and government support to accelerate AI development, Huang told reporters at the Computex trade show in Taipei. The competition in China is already intense, given its strong software capabilities, extensive technology ecosystems and work efficiency, he said. “All in all, the export controls were a failure. The facts would suggest it,” he said. “The US
The government has launched a three-pronged strategy to attract local and international talent, aiming to position Taiwan as a new global hub following Nvidia Corp’s announcement that it has chosen Taipei as the site of its Taiwan headquarters. Nvidia cofounder and CEO Jensen Huang (黃仁勳) on Monday last week announced during his keynote speech at the Computex trade show in Taipei that the Nvidia Constellation, the company’s planned Taiwan headquarters, would be located in the Beitou-Shilin Technology Park (北投士林科技園區) in Taipei. Huang’s decision to establish a base in Taiwan is “primarily due to Taiwan’s talent pool and its strength in the semiconductor
French President Emmanuel Macron has expressed gratitude to Hon Hai Precision Industry Co (鴻海精密) for its plan to invest approximately 250 million euros (US$278 million) in a joint venture in France focused on the semiconductor and space industries. On his official X account on Tuesday, Macron thanked Hon Hai, also known globally as Foxconn Technology Group (富士康科技集團), for its investment projects announced at Choose France, a flagship economic summit held on Monday to attract foreign investment. In the post, Macron included a GIF displaying the national flag of the Republic of China (Taiwan), as he did for other foreign investors, including China-based
RSS